Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Journal of Biomolecular Screening|November 30, 2012
High-throughput screen identifies cyclic nucleotide analogs that inhibit prostatic acid phosphataseEric S McCoy, Wendy A Lea, Bryan T Mott, et al.
Plos One|October 12, 2012
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κKinrin Yamanaka, Dorjbal Dorjsuren, Robert L Eoff, et al.
Drug Development Research|June 2, 2021
A quinazoline-based bromodomain inhibitor, CN210, ameliorates indomethacin-induced ileitis in mice by inhibiting inflammatory cytokine expressionTakehisa Noguchi, Kyosuke Hidaka, Satsuki Kobayashi, et al.
The Biochemical Journal|December 16, 2014
The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding siteJonathan H Clarke, Maria-Luisa Giudici, John E Burke, et al.
Science Translational Medicine|January 11, 2013
Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latencyYu Liang, Jodi L Vogel, Jesse H Arbuckle, et al.
Analytical and Bioanalytical Chemistry|January 7, 2014
A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein bindingMegan M McCallum, Alan J Pawlak, William R Shadrick, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2019
Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseasesShyh-Ming Yang, Makoto Yoshioka, Jeffrey W Strovel, et al.
Bioorganic & Medicinal Chemistry|October 13, 2006
Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibitionClaudia Sissi, Lorena Lucatello, A Paul Krapcho, et al.
Plos One|August 12, 2014
A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2J Brian Jameson, Auric Kantz, Lena Schultz, et al.
Blood Vessels, Thrombosis & Hemostasis|March 30, 2026
VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopeniaAdriana Yamaguchi, Victoria Putzbach, Reheman Adili, et al.
Pageof 11